Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities

Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta-cells in the pancreas, caused by the interplay of genetic and environmental factors. Despite the introduction of advanced technologies for diabetes management, most patients fail to achieve target glycemic control, a...

Full description

Bibliographic Details
Main Authors: Przemysław Beik, Martyna Ciesielska, Maria Kucza, Alicja Kurczewska, Joanna Kuźmińska, Bartosz Maćkowiak, Elżbieta Niechciał
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/9/2805
_version_ 1797555138507833344
author Przemysław Beik
Martyna Ciesielska
Maria Kucza
Alicja Kurczewska
Joanna Kuźmińska
Bartosz Maćkowiak
Elżbieta Niechciał
author_facet Przemysław Beik
Martyna Ciesielska
Maria Kucza
Alicja Kurczewska
Joanna Kuźmińska
Bartosz Maćkowiak
Elżbieta Niechciał
author_sort Przemysław Beik
collection DOAJ
description Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta-cells in the pancreas, caused by the interplay of genetic and environmental factors. Despite the introduction of advanced technologies for diabetes management, most patients fail to achieve target glycemic control, and T1D still has a high burden of long-term end-organ complications. Over several decades, multiple clinical trials have attempted to find prevention for T1D in at-risk individuals or to stabilize, ultimately reverse, the disease in those with T1D. To date, T1D remains yet incurable condition; however, recently improved understanding of the natural history of the disease may lead to new strategies to preserve or improve beta-cell function in those at increased risk and T1D patients. This publication aims to provide an overview of past experiences and recent findings in the prevention of T1D.
first_indexed 2024-03-10T16:42:18Z
format Article
id doaj.art-bfcb3c8332d3459e885b74ba611f592e
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T16:42:18Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-bfcb3c8332d3459e885b74ba611f592e2023-11-20T11:55:46ZengMDPI AGJournal of Clinical Medicine2077-03832020-08-0199280510.3390/jcm9092805Prevention of Type 1 Diabetes: Past Experiences and Future OpportunitiesPrzemysław Beik0Martyna Ciesielska1Maria Kucza2Alicja Kurczewska3Joanna Kuźmińska4Bartosz Maćkowiak5Elżbieta Niechciał6Department of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandDepartment of Pediatric Diabetes and Obesity, Poznan University of Medical Sciences, Szpitalna Street 27/33, 60-572 Poznan, PolandType 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta-cells in the pancreas, caused by the interplay of genetic and environmental factors. Despite the introduction of advanced technologies for diabetes management, most patients fail to achieve target glycemic control, and T1D still has a high burden of long-term end-organ complications. Over several decades, multiple clinical trials have attempted to find prevention for T1D in at-risk individuals or to stabilize, ultimately reverse, the disease in those with T1D. To date, T1D remains yet incurable condition; however, recently improved understanding of the natural history of the disease may lead to new strategies to preserve or improve beta-cell function in those at increased risk and T1D patients. This publication aims to provide an overview of past experiences and recent findings in the prevention of T1D.https://www.mdpi.com/2077-0383/9/9/2805type 1 diabetesautoimmune diseasespreventionbeta-cell functionclinical trials
spellingShingle Przemysław Beik
Martyna Ciesielska
Maria Kucza
Alicja Kurczewska
Joanna Kuźmińska
Bartosz Maćkowiak
Elżbieta Niechciał
Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
Journal of Clinical Medicine
type 1 diabetes
autoimmune diseases
prevention
beta-cell function
clinical trials
title Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
title_full Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
title_fullStr Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
title_full_unstemmed Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
title_short Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
title_sort prevention of type 1 diabetes past experiences and future opportunities
topic type 1 diabetes
autoimmune diseases
prevention
beta-cell function
clinical trials
url https://www.mdpi.com/2077-0383/9/9/2805
work_keys_str_mv AT przemysławbeik preventionoftype1diabetespastexperiencesandfutureopportunities
AT martynaciesielska preventionoftype1diabetespastexperiencesandfutureopportunities
AT mariakucza preventionoftype1diabetespastexperiencesandfutureopportunities
AT alicjakurczewska preventionoftype1diabetespastexperiencesandfutureopportunities
AT joannakuzminska preventionoftype1diabetespastexperiencesandfutureopportunities
AT bartoszmackowiak preventionoftype1diabetespastexperiencesandfutureopportunities
AT elzbietaniechciał preventionoftype1diabetespastexperiencesandfutureopportunities